RGS may not communicate as often as other listed companies, but they surely stick to their strategy with purpose and determination.
In 2009, they started the journey on MSC secretions for acute skin inflammation with a topical cream for dogs. It really worked in reducing skin inflammation. They then worked on developing a proprietary technology around MSCs secretions and they have now secured a patent for the largest market on the planet for acne.
They are so much closer to product development than most of us realise...
Well executed plan!
RGS Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held